Briefing

Lumira Ventures raises US$255M across two healthtech funds

The Toronto-based venture capital firm raised US$220 million for its Fund IV, its largest to date, and another US$35 million for a “strategic fund” in partnership with an undisclosed international pharmaceutical company. Investors in Fund IV include Kensington Capital Partners, Northleaf Capital Partners, Teralys Capital, Fonds de solidarité FTQ, the Caisse de dépôt et placement du Québec, Business Development Bank of Canada, Investissement Québec and Vancity. (The Logic)

    Enter your email to read this article for free

    By entering your e-mail you consent to receiving commercial electronic messages from The Logic Inc. containing news, updates, offers or promotions about The Logic Inc.’s products and services. You can withdraw your consent at anytime. Please refer to our privacy policy or contact us for more details.
    Already a subscriber?

    In-depth, agenda-setting reporting

    Great journalism delivered straight to your inbox.

    Briefing

    Toronto’s BlueCat Networks bought by U.S. PE firm

    BlackBerry’s earnings sink, but stock pops on auto, cybersecurity growth

    Shopify’s Lütke tells staff to expect slower hiring

    Best business newsletter in Canada

    Get up to speed in minutes with insights and analysis on the most important stories of the day, every weekday.

    Exclusive events

    See the bigger picture with reporters and industry experts in subscriber-exclusive events.

    Membership in The Logic Council

    Membership provides access to our popular Slack channel, participation in subscriber surveys and invitations to exclusive events with our journalists and special guests.

    Canada's most influential executives and policymakers are reading The Logic

    • CPP Investments
    • Sun Life Financial
    • C100
    • Amazon
    • Telus
    • Mastercard
    • bdc
    • Shopify
    • Rogers
    • RBC
    • General Motors
    • MaRS
    • Government of Canada
    • Uber
    • Loblaw Companies Limited